Overview
Keiichi Mizushima practices in Sapporo, Japan. Mizushima is rated as an Experienced expert by MediFind in the treatment of Hereditary Ataxia. Their top areas of expertise are Spinocerebellar Ataxia Type 8, Spinocerebellar Ataxia Type 31, Olivopontocerebellar Atrophy, and Spinocerebellar Ataxia Type 4.
Their clinical research consists of co-authoring 10 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Hereditary Ataxia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Cerebellar AtaxiaMizushima isExperienced. Learn about Acute Cerebellar Ataxia.
- Drug Induced DyskinesiaMizushima isExperienced. Learn about Drug Induced Dyskinesia.
- EncephalitisMizushima isExperienced. Learn about Encephalitis.
- Hereditary AtaxiaMizushima isExperienced. Learn about Hereditary Ataxia.
- Lambert-Eaton SyndromeMizushima isExperienced. Learn about Lambert-Eaton Syndrome.
- NeurosarcoidosisMizushima isExperienced. Learn about Neurosarcoidosis.